Trust Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43K Hold
57
﹤0.01% 533
2026
Q1
$3.58K Hold
57
﹤0.01% 488
2025
Q4
$5.43K Hold
57
﹤0.01% 471
2025
Q3
$5.57K Hold
57
﹤0.01% 342
2025
Q2
$6.12K Hold
57
﹤0.01% 343
2025
Q1
$5.75K Hold
57
﹤0.01% 363
2024
Q4
$5.09K Hold
57
﹤0.01% 344
2024
Q3
$4.78K Buy
+57
New +$4.49K ﹤0.01% 316
2021
Q4
Sell
-2,666
Closed -$116K 321
2021
Q3
$116K Hold
2,666
0.03% 139
2021
Q2
$114K Hold
2,666
0.08% 128
2021
Q1
$103K Sell
2,666
-1,334
-33% -$50.5K 0.07% 136
2020
Q4
$144K Hold
4,000
0.11% 112
2020
Q3
$153K Hold
4,000
0.13% 115
2020
Q2
$140K Hold
4,000
0.13% 109
2020
Q1
$131K Hold
4,000
0.14% 93
2019
Q4
$181K Hold
4,000
0.16% 93
2019
Q3
$163K Hold
4,000
0.15% 94
2019
Q2
$172K Hold
4,000
0.16% 92
2019
Q1
$154K Hold
4,000
0.09% 102
2018
Q4
$141K Hold
4,000
0.08% 89
2018
Q3
$154K Hold
4,000
0.07% 89
2018
Q2
$131K Hold
4,000
0.06% 101
2018
Q1
$109K Hold
4,000
0.04% 114
2017
Q4
$99K Buy
+4,000
New +$110K 0.04% 114

Other funds holding BSX

Trust Company's BSX Position: Q2 2026 in Review

Trust Company held its Boston Scientific (BSX) position steady in Q2 2026 at 57 shares worth $2.43K. The position accounts for ﹤0.01% of the portfolio, ranked #533.

Trust Company first reported a position in BSX in Q4 2017 and has held it in 24 quarters since. The position peaked at $181K in Q4 2019. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Trust Company held 57 shares of Boston Scientific worth $2.43K as of Q2 2026.
  • Trust Company left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #533 holding.
  • Trust Company first reported a position in Boston Scientific in Q4 2017 and has held it in 24 quarters since.
  • Trust Company's Boston Scientific position peaked at $181K in Q4 2019.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.